0.0TWD
5.10 MTWD
2.17 BTWD
81.73 M
About HIWIN MIKROSYSTEM CORP
Sector
Industry
CEO
Kuo I Ssu
Website
Headquarters
Taichung
Founded
1997
ISIN
TW0004576004
FIGI
BBG00M979FN8
D Western Therapeutics Institute, Inc is a Japan-based company engaged in the research and development of new pharmaceuticals. The Company generates revenue from licensing of its developed drugs to other companies. As of December 31, 2012, the Company’s drug pipeline included anti-thrombotic medicine K-134, therapeutic agent K-115 for glaucoma, and anticancer drug HMN-214. Its newly-developed products include new anti-thrombotic medicine and signal-transduction inhibitors, including therapeutic agent for high-blood pressure, protective agent for nerves, therapeutic agent for atherosclerosis, ophthalmologic drug and anticancer drug, among others. The Company is also developing new drug candidate compounds focusing on protein kinase inhibitors.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4576 is 70.9 TWD — it has decreased by 4.83% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange HIWIN MIKROSYSTEM CORP stocks are traded under the ticker 4576.
HIWIN MIKROSYSTEM CORP is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
4576 stock is 7.81% volatile and has beta coefficient of 0.54. Check out the list of the most volatile stocks — is HIWIN MIKROSYSTEM CORP there?
4576 earnings for the last quarter are 0.34 TWD per share, whereas the estimation was 0.34 TWD resulting in a 0% surprise. The estimated earnings for the next quarter are 0.09 TWD per share. See more details about HIWIN MIKROSYSTEM CORP earnings.
HIWIN MIKROSYSTEM CORP revenue for the last quarter amounts to 603.00 M TWD despite the estimated figure of 603.00 M TWD. In the next quarter revenue is expected to reach 576.00 M TWD.
Yes, you can track HIWIN MIKROSYSTEM CORP financials in yearly and quarterly reports right on TradingView.
4576 stock has fallen by 11.82% compared to the previous week, the month change is a 4.26% rise, over the last year HIWIN MIKROSYSTEM CORP has showed a 9.45% decrease.
4576 net income for the last quarter is 751.00 K TWD, while the quarter before that showed 16.84 M TWD of net income which accounts for −95.54% change. Track more HIWIN MIKROSYSTEM CORP financial stats to get the full picture.
Today HIWIN MIKROSYSTEM CORP has the market capitalization of 8.93 B, it has decreased by 1.68% over the last week.
Yes, 4576 dividends are paid annually. The last dividend per share was 1.00 TWD. As of today, Dividend Yield (TTM)% is 1.34%. Tracking HIWIN MIKROSYSTEM CORP dividends might help you take more informed decisions.
HIWIN MIKROSYSTEM CORP dividend yield was 0.15% in 2023, and payout ratio reached 234.74%. The year before the numbers were 1.44% and 36.64% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 4576 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HIWIN MIKROSYSTEM CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HIWIN MIKROSYSTEM CORP technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HIWIN MIKROSYSTEM CORP stock shows the sell signal. See more of HIWIN MIKROSYSTEM CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HIWIN MIKROSYSTEM CORP EBITDA is 195.47 M TWD, and current EBITDA margin is 8.87%. See more stats in HIWIN MIKROSYSTEM CORP financial statements.